Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Old API Wind-down Ltd - Ordinary Shares ARLZQ

"Old API Wind-down Ltd, formerly Aralez Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in the acquisition, development, and commercialization of products primarily in cardiovascular, pain management and other specialty areas. Its key products include Fiorinal, Proferrin, Fibricor, Uracyst and Neovisc, Cambia and other marketed products. The company currently... see more

OTCPK:ARLZQ - Post Discussion

View:
Post by CHECKMATE77 on Sep 14, 2016 8:36pm

Calm down

There have been zero announcements from fda or company
we do not know the result ,even if the is one
until then calm down
Comment by 2quick154 on Sep 14, 2016 9:00pm
Emailed them about 30 mins ago and they said they are still waiting to hear from fda... Lol take it for what it's worth.
Comment by kuatolives on Sep 14, 2016 9:04pm
Like 10 drinks in. Lot to ask from a drunk. 
Comment by kuatolives on Sep 14, 2016 10:18pm
Unless a bunch of lazy government employees are (unlikely) working till midnight, ArLZ is still trying to "craft" a press release that somehow will attempt to prevent the annihilation of their stock. Hope I'm wrong. 12 drinks in! Woot!
Comment by PoorOpinion on Sep 14, 2016 10:28pm
Maudlin drunk, push through to silly, avoiding angry.
Comment by kuatolives on Sep 14, 2016 10:42pm
Watcha want?
Comment by kuatolives on Sep 14, 2016 10:51pm
At the casino with my bud; somehow down a grand is a pittance to down half a mil. Rum is good though. Yee!
Comment by kuatolives on Sep 14, 2016 11:51pm
10 mins or everyone is a lying crook fck.
Comment by kuatolives on Sep 15, 2016 12:01am
It's now sept 15. Everyone is officially a lying stealing crook. 
Comment by biggerr on Sep 15, 2016 12:32am
they are located in Vancouver, BC so it's still Sept.14 here, ha
Comment by kuatolives on Sep 15, 2016 1:19am
So just about a bunch of crooked fxks or what?
Comment by 2quick154 on Sep 15, 2016 1:23am
CRL in the am?
Comment by kuatolives on Sep 15, 2016 2:02am
Criminal fxks. 14 rums. Prepared biatches!!!
Comment by kuatolives on Sep 15, 2016 2:04am
Cryin won't help you, praying won't do you no good. When the levee breaks ...
Comment by kuatolives on Sep 15, 2016 3:30am
Am I the only one still up? Pussies. 
Comment by snootchybootchy on Sep 15, 2016 3:57am
I'm still up.  I'm no puss#! Saw this on twitter just now.  Somebody received an e-mail from Aralez's IR person (Nichol Ochsner) late this evening.   
Comment by 90guppy on Sep 14, 2016 10:41pm
Kuato, somehow, you made me laugh, don't forget to call the cab before you go home
Comment by biggerr on Sep 14, 2016 9:00pm
including AH this stock dropped 22% today which means that if there is approval tomorrow we'll get back to yesterday's price. Given that clinical trials were good and FDA inspected the aspirin supplier recently and found no problems I don't see why they should reject the application
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities